Brief: Neovacs To Present Pre-Clinical Results Of IFNalpha Kinoid
05/06/2019 06:33
June 5 (Reuters) - Neovacs SA ALNEV.PA :
* REG-NEOVACS TO PRESENT THE PRE-CLINICAL RESULTS OF ITS
IFNALPHA
KINOID TO TREAT TYPE 1 DIABETES - AMERICAN DIABETES
ASSOCIATION'S 79TH SCIENTIFIC SESSIONS
Source text for Eikon: ID:nGNE1YYL3c
Further company coverage: ALNEV.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Neovacs SA
See all newsBrief: Neovacs And FOCH Hospital Commit To Partnership On Research In Pneumology And Allergology
Brief: Neovacs Presented Latest Results On Its Vaccine Candidates Targeting Allergies
Brief: Neovacs H1 Gross Cash Position Down At EUR 6.2 Mln
Brief: Neovacs: Signature Of Trust Agreement For Equitization Of Bonds Redeemable In Shares With Share Warrants
Brief: Neovacs Launches A Public Offering Of Bonds Redeemable In Shares With Stock Warrants